Quarterly Statement as of 30 June 2022
BRAIN Biotech AG, 29 August 2022
Our products and solutions directly address the sustainability goals of the United Nations: 2, 3, 6, 9, and 12.
Among other things, we aim to replace petrochemical processes by biotechnological processes, based on our proprietary resource collection, the BRAIN BioArchive.
Our innovative solutions (Tailor-made-solutions, TMS) as well as our products business show a low correlation with economic cycles and enable structural growth.
We have a broad and profound technological expertise in enzymes, microorganisms, cell-based testing methods and natural products. Combined with our collection of natural resources, the BRAIN BioArchive, we develop disruptive new biobased products and solutions.
In more than 100 successfully completed R&D partnerships (Tailor made Solutions, TMS) we have proven our competence and reliability.
Our proprietary BRAIN BioArchive, an extensive patent portfolio, our broad and in-depth technology know-how as well as our first class scientists build high barriers to market entry.